Semaglutide improves cardiometabolic risk factors in adults with overweight or obesity: STEP 1 and 4 exploratory analyses.
Mikhail Naum KosiborodMeena BhattaMelanie Jane DaviesJohn E DeanfieldW Timothy GarveyUsman KhalidRobert KushnerDomenica M RubinoNiels ZeuthenSubodh VermaPublished in: Diabetes, obesity & metabolism (2022)
STEP 1 NCT03548935, STEP 4 NCT03548987.